| Literature DB >> 29467298 |
Joe L Hsu1,2, Olga V Manouvakhova2, Karl V Clemons3,4, Mohammed Inayathullah5, Allen B Tu2, Raymond A Sobel6,7, Amy Tian2, Hasan Nazik3,4,8, Venkata R Pothineni5, Shravani Pasupneti1,2, Xinguo Jiang2, Gundeep S Dhillon1, Harmeet Bedi1, Jayakumar Rajadas1,5, Hubertus Haas9, Laure Aurelian10, David A Stevens3,4, Mark R Nicolls11,2.
Abstract
Invasive pulmonary disease due to the mold Aspergillus fumigatus can be life-threatening in lung transplant recipients, but the risk factors remain poorly understood. To study this process, we used a tracheal allograft mouse model that recapitulates large airway changes observed in patients undergoing lung transplantation. We report that microhemorrhage-related iron content may be a major determinant of A. fumigatus invasion and, consequently, its virulence. Invasive growth was increased during progressive alloimmune-mediated graft rejection associated with high concentrations of ferric iron in the graft. The role of iron in A. fumigatus invasive growth was further confirmed by showing that this invasive phenotype was increased in tracheal transplants from donor mice lacking the hemochromatosis gene (Hfe-/- ). The invasive phenotype was also increased in mouse syngrafts treated with topical iron solution and in allograft recipients receiving deferoxamine, a chelator that increases iron bioavailability to the mold. The invasive growth of the iron-intolerant A. fumigatus double-knockout mutant (ΔsreA/ΔcccA) was lower than that of the wild-type mold. Alloimmune-mediated microvascular damage and iron overload did not appear to impair the host's immune response. In human lung transplant recipients, positive staining for iron in lung transplant tissue was more commonly seen in endobronchial biopsy sections from transplanted airways than in biopsies from the patients' own airways. Collectively, these data identify iron as a major determinant of A. fumigatus invasive growth and a potential target to treat or prevent A. fumigatus infections in lung transplant patients.Entities:
Mesh:
Substances:
Year: 2018 PMID: 29467298 PMCID: PMC5841257 DOI: 10.1126/scitranslmed.aag2616
Source DB: PubMed Journal: Sci Transl Med ISSN: 1946-6234 Impact factor: 17.956